Relation of epidermal growth factor receptor expression to mucus hypersecretion in diffuse panbronchiolitis

Area of Science:

• Pulmonary Medicine
• Respiratory Diseases
• Pathology

Background:

• Diffuse panbronchiolitis (DPB) is characterized by excessive mucus production, but the underlying mechanisms remain unclear.
• Neutrophilic inflammation and epidermal growth factor receptor (EGFR) signaling are implicated in airway hypersecretory diseases.
• Goblet cell degranulation, a key process in mucus secretion, is influenced by neutrophilic elastase.

Purpose of the Study:

• To investigate the association between EGFR expression, neutrophilic inflammation, and mucus hypersecretion in DPB patients.
• To explore the role of goblet cell metaplasia and degranulation in the pathogenesis of DPB.

Main Methods:

• Tissue samples from 13 DPB patients and 6 healthy controls were analyzed.
• Alcian blue/periodic acid-Schiff (AB/PAS) staining was used to assess mucous glycoconjugates.
• Immunohistochemical staining identified MUC5AC, EGFR, tumor necrosis factor-alpha, and CD16 (neutrophils).

Main Results:

• DPB patients exhibited significantly higher neutrophilic inflammation compared to controls (p = 0.002).
• Goblet cell metaplasia and MUC5AC expression were significantly elevated in DPB bronchiolar epithelium (p = 0.001 and p = 0.002).
• Increased intraluminal mucus secretion, indicative of goblet cell degranulation, was observed in DPB tissues (p = 0.001), with EGFR expression present in the bronchiolar epithelium.

Conclusions:

• Mucus hypersecretion in DPB is closely associated with neutrophilic inflammation and EGFR expression.
• Goblet cell metaplasia and degranulation play significant roles in DPB mucus overproduction.
• Neutrophilic inflammation appears to drive goblet cell degranulation in DPB.